FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/030102 [Registered on: 29/12/2020] Trial Registered Prospectively
Last Modified On: 25/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy of Pashanbhedadi Churna in the Ashmari management 
Scientific Title of Study   Efficacy of Pashanbhedadi Churna in the management of Ashmari(Renal Calculi)-An open Labelled Randomized Controlled Clinical Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Hetal G Koriya 
Designation  MS 1st Year 
Affiliation  IPGT and RA Jamnagar 
Address  Shalyatantra Department 6th floor IPGT RA Jamnagar
Opd no 1 Sushrut Bhavan IPGT RA Jamnagar
Jamnagar
GUJARAT
361008
India 
Phone  9033785547  
Fax    
Email  hetalkoriya66@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr T S Dudhamal 
Designation  Associate Professor 
Affiliation  IPGT and RA Jamnagar 
Address  Shalyatantra Department 6th floor IPGT RA Jamnagar
Opd no 1 Sushrut Bhavan IPGT RA Jamnagar
Jamnagar
GUJARAT
361008
India 
Phone  9428671939  
Fax    
Email  dudhamal@ayurveduniversity.com  
 
Details of Contact Person
Public Query
 
Name  Dr T S Dudhamal 
Designation  Associate Professor 
Affiliation  IPGT and RA Jamnagar 
Address  Shalyatantra Department 6th floor IPGT RA Jamnagar
Opd no 1 Sushrut Bhavan IPGT RA Jamnagar
Jamnagar
GUJARAT
361008
India 
Phone  9428671939  
Fax    
Email  dudhamal@ayurveduniversity.com  
 
Source of Monetary or Material Support  
Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar Gujarat 361008 
 
Primary Sponsor  
Name  Institute for post graduate and research center 
Address  Gujarat Ayurved University Jamnagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Hetal G Koriya  Shalya Tantra Department OPD No.1,IPGT and RA,JAMNAGAR  6th Floor, Shalya Tantra Department
Jamnagar
GUJARAT 
9033785547

hetalkoriya66@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:3||Administration. Ayurveda Condition: ASMARI, (2) ICD-10 Condition: N200||Calculus of kidney, (3) ICD-10 Condition:N200||Calculus of kidney. Ayurveda Condition: Ashmari(Renal Calculi),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ashmarihar Kwath  Group A patient will be treated with Ashmarihar kwath for 60days 10gm yavkut BD 
Comparator Agent  Pashanbhedadi Churna  Group B patient will be treated with Pashanbhedadi Churna for 60days 5gm BD 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  stone size upto 10mm
patients of Ashmari with controlled HTN and DM
case of only renal stone will be included 
 
ExclusionCriteria 
Details  age below 18 and above 60years
chronic renal failure( Sr.Creatinine>2mg/dl not included)
gross hydronephrosis
acute abdominal pain
cases which require surgical intervention
severe haematuria
stone size>10mm
stone present in urinary bladder,ureter,urethra
known cases of malignancy and tuberculosis
uncontrolled HTN,DM,Cardiac disorders 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relief in Signs and Symptoms of Renal Calculi
Reduction in Stone Size
Expelled out of Stone 
Outcome will be assessed after 8 weeks. 
 
Secondary Outcome  
Outcome  TimePoints 
Improve Quality of Life of Person  Assessment will be done after 8 weeks  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="42" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   04/01/2021 
Date of Study Completion (India) 14/09/2021 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
total 50 patients were divided into two groups by randomization.among them 8 patients were dropped out.in group A patients were treated with Ashmarihaara Kwatha and Yava Kshara and in group B patients were treated with Pashanbhedadi Churna for 60 days with follow up of 30 days.at the end of the study  sifnificant result was found in group A  Iin both subjective and objective parameters while better result was found in subjective parameter in group B and both the drugs also showed good result in positive urine culture. 
Close